Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127879451 | 12787945 | 1 | I | 201606 | 20160922 | 20160928 | 20160928 | EXP | US-AMGEN-USASP2016131297 | AMGEN | 66.00 | YR | E | M | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127879451 | 12787945 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | LONGER DURATION GRANULATION STIMULATING MEDICATION | D | 125031 | UNKNOWN FORMULATION | ||||||||
| 127879451 | 12787945 | 2 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DOSE WAS BASED ON WEIGHT (3 IN 1 WK) | 0 | SOLUTION FOR INFUSION | TIW | ||||||||
| 127879451 | 12787945 | 3 | SS | RITUXAN | RITUXIMAB | 1 | 0 | SOLUTION FOR INFUSION | |||||||||||
| 127879451 | 12787945 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127879451 | 12787945 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127879451 | 12787945 | 6 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | UNK | 0 | ||||||||||
| 127879451 | 12787945 | 7 | SS | DOXORUBICIN | DOXORUBICIN | 1 | 0 | ||||||||||||
| 127879451 | 12787945 | 8 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | UNK | 0 | ||||||||||
| 127879451 | 12787945 | 9 | SS | VINCRISTINE | VINCRISTINE | 1 | 0 | ||||||||||||
| 127879451 | 12787945 | 10 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | 0 | ||||||||||
| 127879451 | 12787945 | 11 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 0 | ||||||||||||
| 127879451 | 12787945 | 12 | C | CLARITIN | LORATADINE | 1 | 10 MG, QD (1 IN 1 D) | 0 | 10 | MG | QD | ||||||||
| 127879451 | 12787945 | 13 | C | CLARITIN | LORATADINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127879451 | 12787945 | 1 | Neutropenia |
| 127879451 | 12787945 | 2 | Lymphoma |
| 127879451 | 12787945 | 3 | Non-Hodgkin's lymphoma |
| 127879451 | 12787945 | 4 | Lymphoma |
| 127879451 | 12787945 | 5 | Non-Hodgkin's lymphoma |
| 127879451 | 12787945 | 6 | Lymphoma |
| 127879451 | 12787945 | 7 | Non-Hodgkin's lymphoma |
| 127879451 | 12787945 | 8 | Lymphoma |
| 127879451 | 12787945 | 9 | Non-Hodgkin's lymphoma |
| 127879451 | 12787945 | 10 | Lymphoma |
| 127879451 | 12787945 | 11 | Non-Hodgkin's lymphoma |
| 127879451 | 12787945 | 12 | Bone pain |
| 127879451 | 12787945 | 13 | Seasonal allergy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127879451 | 12787945 | OT |
| 127879451 | 12787945 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127879451 | 12787945 | Asthenia | |
| 127879451 | 12787945 | Bone pain | |
| 127879451 | 12787945 | Decreased appetite | |
| 127879451 | 12787945 | Drug ineffective | |
| 127879451 | 12787945 | Fatigue | |
| 127879451 | 12787945 | Neutropenia | |
| 127879451 | 12787945 | Oropharyngeal pain | |
| 127879451 | 12787945 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127879451 | 12787945 | 2 | 201603 | 20160714 | 0 | |
| 127879451 | 12787945 | 4 | 201603 | 0 | ||
| 127879451 | 12787945 | 6 | 201603 | 0 | ||
| 127879451 | 12787945 | 8 | 201603 | 0 | ||
| 127879451 | 12787945 | 10 | 201603 | 0 |